Guiding ATMPs to patients

Here you will find information on what is happening in Sweden in development of medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. We welcome your collaboration towards accelerated and efficacious patient solutions.

Register for ATMP Sweden 2020 in Stockholm!

Register for Sweden's premiere annual ATMP conference!

Join us in Stockholm April 1-3, 2020. Sponsorship package now available! Find our more here!

Read more

Subscribe to our mailing list

Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.

Follow us on LinkedIn!


Check out the ATMP map

Use our interactive map to find clinics, manufacture facilities and CAMP/Swelife-ATMP partners.

The ATMP regulatory guide

Use this guide to navigate development of your ATMP to Phase I!

What are ATMPs?

What is the difference between a transplant and a cell based ATMP?


Financing ATMPs – Bedside to Reimbursement


Part 2 of our September 2019 ATMP financing events in Skåne.

Read more

200 million SEK investment in Swedish gene and immunotherapy production


Cobra Biologics invests 200 million SEK in Matfors facility

Read more

Swedish based Ilya Pharma recruiting for first ATMP trial


Genetically engineered bacteria to drive wound healing

Read more
Display all news




Open meeting: Business models and health economics





Advanced bioreactor cultivation technology





Cell and Gene Therapy course


Show all events

Work with us!

CAMP partners

Join our experts in the science and technology for GMP compliant clinical translation of ATMPs.

Swelife-ATMP partners

Join our experts in the knowledge, processes and competencies for getting ATMPs to patients.

We want to hear about your activities!

Help us to help you get information out about your ATMP press releases or events in Sweden!

ATMP success stories

From 'bubble babies' to cancer - How ATMPs are revolutionising medicine

There are cell and gene therapies being developed all over the world for a variety of indications. Find our more about ATMP successes here!

Read more

Other collaborating national projects

VOG Cell

VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.


AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.

Future Medicine

This Group will be developing a long term strategy for the future of the ATMP field in Sweden. The Project will ensure that all necessary networks and stakeholders are involved.

See all ATMP relevant organisations here